Certara, Inc. (CERT)
NASDAQ: CERT · Real-Time Price · USD
10.76
-0.25 (-2.27%)
At close: Jun 16, 2025, 4:00 PM
10.79
+0.03 (0.28%)
After-hours: Jun 16, 2025, 7:59 PM EDT
Certara Employees
As of December 31, 2024, Certara had 1,546 total employees, including 1,487 full-time and 59 part-time employees. The number of employees increased by 155 or 11.14% compared to the previous year.
Employees
1,546
Change (1Y)
155
Growth (1Y)
11.14%
Revenue / Employee
$255,173
Profits / Employee
-$1,698
Market Cap
1.75B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,546 | 155 | 11.14% |
Dec 31, 2023 | 1,391 | 187 | 15.53% |
Dec 31, 2022 | 1,204 | 90 | 8.08% |
Dec 31, 2021 | 1,114 | 211 | 23.37% |
Dec 31, 2020 | 903 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CERT News
- 6 weeks ago - Certara, Inc. (CERT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Certara Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Certara to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report - Benzinga
- 2 months ago - Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing - GlobeNewsWire
- 2 months ago - Buy Certara After The FDA Announcement - Seeking Alpha
- 2 months ago - What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday? - Benzinga
- 2 months ago - Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities - GlobeNewsWire